SQSTM1 and neoplasm: Inhibition of autophagy would also lead to p62 accumulation and constitutive activation of Nrf2, offering tumor cells a defense against oxidative stress-inducing agents supporting the development of Nrf2 inhibitors as a therapeutic tool to enhance the function of chemotherapeutic drugs.